Background. Herpes simplex virus type 2 (HSV-2) reactivations are associated with increased HIV load, but whether HSV-2 coinfection accelerates HIV disease is unclear. We compared rates of CD4 count ...
Background: Herpes simplex virus type 2 (HSV-2) is an important cause of genital ulcers and can increase the risk for human immunodeficiency virus type 1 (HIV-1) transmission. Our objective was to ...
A combination drug used to treat and prevent HIV -- Truvada -- may have an additional benefit: lowering the risk of a genital herpes infection, a new study suggests. Researchers found that African ...
Prevention—what doesn’t work? In a session entitled “Status of the U.S. HIV/AIDS Epidemic: Is It Changing and If Not, Why Not?” Harold Jaffe, MD, former head of the CDC, discussed a not-yet-published ...
First-in-human study aims to evaluate the safety and immunogenicity of prophylactic herpes virus vaccine candidate BNT163 BNT163 is the first candidate from BioNTech’s infectious disease mRNA vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback